ArticlePharmaceutics2020

Development of Liposomal Vesicles for Osimertinib Delivery to EGFR Mutation-Positive Lung Cancer Cells.

Paulina Skupin-Mrugalska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.